ArticleChinese medical journal2021

Corrigendum: Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.